The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial

Journal of Cardiac Failure - Tập 27 - Trang 1359-1366 - 2021
FOUAD CHOUAIRI1,2,3, MICHAEL A. FUERY2,4, CLANCY W. MULLAN5, CESAR CARABALLO1,6, SOUNOK SEN1,2, CHRISTOPHER MAULION1,2, SAMUEL T. WILKINSON6,7, TORAL SURTI6,7, MEGAN MCCULLOUGH8, P. ELLIOTT MILLER1,2, JUSTIN PACOR2,4, ERIC S. LEIFER9, G. MICHAEL FELKER10, ERIC J. VELAZQUEZ1,2, MONA FIUZAT10, CHRISTOPHER M. O'CONNOR11, JAMES L JANUZZI8, NIHAR R. DESAI1,2,6, TARIQ AHMAD1,2
1Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut
2Yale University School of Medicine, New Haven, Connecticut
3Department of Internal Medicine, Duke University University School of Medicine, Durham, North Carolina
4Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
5Department of Cardiac Surgery, Yale University School of Medicine, New Haven, CT
6Center for Outcomes Research & Evaluation (CORE), Yale University School of Medicine, New Haven, Connecticut
7Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
8Massachusetts General Hospital, Boston, Massachusetts
9Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland
10Duke Clinical Research Institute, Durham, North Carolina
11INOVA Heart and Vascular Institute, Falls Church, Virginia

Tài liệu tham khảo

Mozaffarian, 2016, Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association, Circulation, 133, 447, 10.1161/CIR.0000000000000366 Rutledge, 2006, Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes, J Am Coll Cardiol, 48, 1527, 10.1016/j.jacc.2006.06.055 O'Connor, 2010, Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial, J Am Coll Cardiol, 56, 692, 10.1016/j.jacc.2010.03.068 Angermann, 2016, Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial, JAMA, 315, 2683, 10.1001/jama.2016.7635 Felker, 2017, Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial, JAMA, 318, 713, 10.1001/jama.2017.10565 Mark, 2018, Economic and quality-of-life outcomes of natriuretic peptide-guided therapy for heart failure, J Am Coll Cardiol, 72, 2551, 10.1016/j.jacc.2018.08.2184 Green, 2000, Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure, J Am Coll Cardiol, 35, 1245, 10.1016/S0735-1097(00)00531-3 Andresen, 1994, Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale), Am J Prev Med, 10, 77, 10.1016/S0749-3797(18)30622-6 O'Connor, 2019, Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score, Eur J Heart Failure, 21, 770, 10.1002/ejhf.1450 Jani, 2016, Comorbid depression and heart failure: a community cohort study, PloS One, 11, 10.1371/journal.pone.0158570 Warraich, 2018, Physical function, frailty, cognition, depression, and quality of life in hospitalized adults ≥60 years with acute decompensated heart failure with preserved versus reduced ejection fraction, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.005254 Freedland, 2016, Depression and multiple rehospitalizations in patients with heart failure, Clin Cardiol, 39, 257, 10.1002/clc.22520 Rumsfeld, 2003, Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure, J Am Coll Cardiol, 42, 1811, 10.1016/j.jacc.2003.07.013 Angermann, 2018, Depression, anxiety, and cognitive impairment: comorbid mental health disorders in heart failure, Curr Heart Fail Rep, 15, 398, 10.1007/s11897-018-0414-8 Herrmann-Lingen, 2003, High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure, Psychosom Med, 65, 517, 10.1097/01.PSY.0000073870.93003.C4 Ertl, 1997, Remodeling of the brain post myocardial infarction: focus on central ANF, Basic Res Cardiol, 92, 82, 10.1007/BF00805567 Carney, 2005, Depression, the autonomic nervous system, and coronary heart disease, Psychosom Med, 67, S29, 10.1097/01.psy.0000162254.61556.d5 Hughes, 2004, Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women, J Psychosom Res, 57, 353, 10.1016/S0022-3999(04)00064-9 Freedland, 2011, Effect of depression on prognosis in heart failure, Heart Fail Clin, 7, 11, 10.1016/j.hfc.2010.08.003 Bhatt, 2016, Depression in heart failure: can PHQ-9 help?, Int J Cardiol, 221, 246, 10.1016/j.ijcard.2016.07.057 Rajeswaran, 2018, The effect of antidepressant medications in the management of heart failure onoutcomes: mortality, cardiovascular function and depression - a systematic review, Int J Psychiatry Clin Pract, 22, 164, 10.1080/13651501.2017.1401085 Das, 2019, Comparison of treatment options for depression in heart failure: a network meta-analysis, J Psychiatr Res, 108, 7, 10.1016/j.jpsychires.2018.10.007 Freedland, 2015, Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial, JAMA Intern Med, 175, 1773, 10.1001/jamainternmed.2015.5220 Abdelbasset, 2019, A randomized controlled trial on the impact of moderate-intensity continuous aerobic exercise on the depression status of middle-aged patients with congestive heart failure, Medicine (Baltimore), 98, e15344, 10.1097/MD.0000000000015344